-
Divergent WNT Signaling and Drug Sensitivity Profiles within Hepatoblastoma Tumors and Organoids
Study
EGAS50000000561
-
Identification and characterization of tertiary lymphoid structures in brain metastases
Study
EGAS50000000563
-
Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trial
Study
EGAS50000000525
-
3D genome topology distinguishes molecular subgroups of medulloblastoma
Study
EGAS50000000540
-
Multiple myeloma treated with T-cell redirecting immunotherapies
Study
EGAS50000000546
-
Whole exome sequencing of pre-invasive lung adenocarcinoma in non-smokers
Study
EGAS50000000438
-
Selective Elimination of Immunosuppressive T cells in Patients with Multiple Myeloma
Study
EGAS00001004915
-
Characterization of copy number quiet oral cancer
Study
EGAS50000000558
-
Tumor Evolution Analysis Uncovered Immune-Escape Related Mutations in Relapsed Diffuse Large B-Cell Lymphoma
Study
EGAS50000000032
-
Cancer cell and tumor microenvironment biomarkers associated with disease-free survival with adjuvant nivolumab in the phase 3 CheckMate 274 trial
Study
EGAS50000000560